The term “autoimmune disease” refers to a different type of illnesses that involve almost every human organ system.
The North America Autoimmune Diagnostics Market was worth $5.48 billion in 2016 and estimated to reach $ 6.48 billion by the end of 2021 with a growing potential of 3.40%.
It includes diseases of the nervous, endocrine systems, gastrointestinal and other connective tissues, blood, eyes and blood vessels.
NIH expected that up to 23.5 million Americans have an Auto immune disorders.
So NIH estimates that the annual direct health spending on auto immune diagnostics is nearly 100 billion (USD).with 50 million Americans living and copying with auto immune disorders more than 75% of them are women. Autoimmune diseases affect women three times more than men.
Some of these diseases have even more higher incidence in women. Autoimmune diseases have been mentioned in the top ten leading causes of the deaths among U.S.
women aged 65 and younger. So these diseases represent the fourth largest cause of disability among women in the United States.
Full report at: www.marketdataforecast.com/market-…tics-market-1191/
In North America, the U.S. and Canada have emerged as the most lucrative markets for autoimmune disease diagnostics. So, both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques, and increasing awareness about various medical procedures.
The overall high healthcare expenditure across the region, puts North America at the front in the global autoimmune disease diagnostics market
Supportive government policies and Increasing public awareness, increasing occurrence of Auto immune disorders, advancements in health care and improved laboratory techniques are the factors driving the growth of the market. The key restraints that hindering the growth of the auto immune diagnostics market are growing rate of diagnostics errors and low occurrence of localized auto immune disorders as compared to systemic diseases.
The North America Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.
Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others.
Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Ankylosing Spondylitis.
Based on End users into Hospitals, Research centers, and diagnostic laboratories and on the basis of geography, the North America Auto immune Diagnostics market is analysed under various regions namely US, and Canada.
Request sample: http://www.marketdataforecast.com/market-reports/north-america-autoimmune-diagnostics-market-1191/request-sample
Some of the major companies dominating the North America Auto immune disease market by their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!